{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:42:36Z","timestamp":1773200556282,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.035","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T19:25:49Z","timestamp":1667244349000},"page":"7219-7229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate"],"prefix":"10.1016","volume":"40","author":[{"given":"Chao","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0272-8332","authenticated-orcid":false,"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.10.035_b0005","doi-asserted-by":"crossref","first-page":"198151","DOI":"10.1016\/j.virusres.2020.198151","article-title":"Classical swine fever virus: the past, present and future","volume":"289","author":"Ganges","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2022.10.035_b0010","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1099\/jgv.0.000873","article-title":"Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae","volume":"98","author":"Smith","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.aivir.2015.03.002","article-title":"The molecular biology of pestiviruses","volume":"93","author":"Tautz","year":"2015","journal-title":"Adv Virus Res"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2022.10.035_b0020","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1099\/0022-1317-77-11-2737","article-title":"Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge","volume":"77","author":"van Rijn","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.20506\/rst.31.3.2173","article-title":"Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals","volume":"31","author":"Schroeder","year":"2012","journal-title":"Rev Sci Tech"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2022.10.035_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/tbed.12676","article-title":"Epidemiology, diagnosis and control of classical swine fever: recent developments and future challenges","volume":"65","author":"Postel","year":"2018","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2022.10.035_b0035","first-page":"13","article-title":"Research progress and challenges in vaccine development against classical swine fever virus","author":"Wei","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.10.035_b0040","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1292\/jvms.20-0654","article-title":"The formation process of button ulcers in pigs experimentally infected with a subgenotype 2.1 isolate of classical swine fever virus","volume":"83","author":"Sudo","year":"2021","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2022.10.035_b0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vetmic.2019.04.001","article-title":"Virulence evaluation of classical swine fever virus subgenotype 2.1 and 2.2 isolates circulating in China","volume":"232","author":"Gong","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0050","first-page":"9","article-title":"Comparison of the pathogenicity of classical swine fever virus subgenotype 2.1c and 2.1d strains from China","author":"Hao","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2022.10.035_b0055","doi-asserted-by":"crossref","first-page":"108915","DOI":"10.1016\/j.vetmic.2020.108915","article-title":"Different clinical presentations of subgenotype 2.1 strain of classical swine fever infection in weaned piglets and adults, and long-term cross-protection conferred by a C-strain vaccine","volume":"253","author":"Wang","year":"2021","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0060","doi-asserted-by":"crossref","first-page":"e29310","DOI":"10.1371\/journal.pone.0029310","article-title":"Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity","volume":"7","author":"Graham","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.10.035_b0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.meegid.2016.04.002","article-title":"Genetic diversity of subgenotype 2.1 isolates of classical swine fever virus","volume":"41","author":"Gong","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0070","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1128\/JVI.73.12.10224-10235.1999","article-title":"Mutations abrogating the RNase activity in glycoprotein E(rns) of the pestivirus classical swine fever virus lead to virus attenuation","volume":"73","author":"Meyers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0075","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/JVI.01710-08","article-title":"Mutation of cysteine 171 of pestivirus E rns RNase prevents homodimer formation and leads to attenuation of classical swine fever virus","volume":"83","author":"Tews","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0080","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.72.3.2544-2547.1998","article-title":"N-terminal protease of pestiviruses: identification of putative catalytic residues by site-directed mutagenesis","volume":"72","author":"Rumenapf","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1743-422X-7-378","article-title":"Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China","volume":"7","author":"Chen","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2022.10.035_b0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-1135(00)00195-4","article-title":"Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains","volume":"74","author":"Mittelholzer","year":"2000","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.celrep.2012.12.001","article-title":"Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry","volume":"3","author":"El Omari","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2022.10.035_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1297-9716-43-33","article-title":"Characterization of C-strain \u201cRiems\u201d TAV-epitope escape variants obtained through selective antibody pressure in cell culture","volume":"43","author":"Leifer","year":"2012","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2022.10.035_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2014.09.021","article-title":"Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability","volume":"471\u2013473","author":"Holinka","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2022.10.035_b0110","doi-asserted-by":"crossref","first-page":"e0177433","DOI":"10.1371\/journal.pone.0177433","article-title":"Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G","volume":"12","author":"Holinka","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.10.035_b0115","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2019.04.076","article-title":"Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE(rns)) in pregnant sows","volume":"37","author":"Lim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.035_b0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jviromet.2009.09.012","article-title":"Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals","volume":"163","author":"Kortekaas","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.10.035_b0125","first-page":"9","article-title":"Assessing the protective dose of a candidate DIVA vaccine against classical swine fever","author":"Jelsma","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.10.035_b0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2015.03.009","article-title":"Discrimination within epitope specific antibody populations against Classical swine fever virus is a new means of differentiating infection from vaccination","volume":"420","author":"Bruderer","year":"2015","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2022.10.035_b0135","first-page":"9","article-title":"Protection of piglets with maternally derived antibodies from sows inoculated with an attenuated live marker classical swine fever vaccine (Flc-LOM-BE(rns))","author":"Choe","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2022.10.035_b0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13567-017-0457-y","article-title":"A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn((R)) CSF Marker): a review of vaccine properties","volume":"48","author":"Blome","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2022.10.035_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jvetres-2017-0001","article-title":"Characterisation of newly emerged isolates of classical swine fever virus in China, 2014\u20132015","volume":"61","author":"Leng","year":"2017","journal-title":"J Vet Res"},{"key":"10.1016\/j.vaccine.2022.10.035_b0150","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1128\/JVI.00672-14","article-title":"Prolonged activity of the pestiviral RNase Erns as an interferon antagonist after uptake by clathrin-mediated endocytosis","volume":"88","author":"Zurcher","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1139\/W09-013","article-title":"Classical swine fever virus Erns glycoprotein antagonizes induction of interferon-beta by double-stranded RNA","volume":"55","author":"Luo","year":"2009","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virusres.2008.10.015","article-title":"The viral RNase E(rns) prevents IFN type-I triggering by pestiviral single- and double-stranded RNAs","volume":"140","author":"Matzener","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2022.10.035_b0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0076-6879(01)42564-X","article-title":"Erns protein of pestiviruses","volume":"342","author":"Hulst","year":"2001","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0170","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1099\/vir.0.2008\/003749-0","article-title":"RNase-dependent inhibition of extracellular, but not intracellular, dsRNA-induced interferon synthesis by Erns of pestiviruses","volume":"89","author":"Magkouras","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1099\/jgv.0.000990","article-title":"Restoration of glycoprotein E(rns) dimerization via pseudoreversion partially restores virulence of classical swine fever virus","volume":"99","author":"Tucakov","year":"2018","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.10.035_b0180","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1128\/JVI.02372-06","article-title":"Bovine viral diarrhea virus: prevention of persistent fetal infection by a combination of two mutations affecting Erns RNase and Npro protease","volume":"81","author":"Meyers","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:27Z","timestamp":1759403967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22012932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":36,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22012932"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}